ALPS logo

ALPS GROUP INC

ALPSNASDAQ
🏆 #4329 by market capUS Equity
$0.40▼ $0.00 (−0.03%)
Market closed · at close
🔔
Track ALPS
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 0.0%
7d▲ 0.0%
14d▼ 0.3%
30d▲ 3.5%
ytd▼ 56.3%
1y—
🏦Market Cap
$66M
Small Cap
📈Revenue Growth (YoY)
+44.1%
High Growth
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
44
Weak

Trading Snapshot

Day Range
$0.39 – $0.40
52-Week Range
$0.23 – $12.01
Volume
$3.27B
Avg Volume
$3.30B
Shares Outstanding
166.4M
Next Earnings
Nov 23, 2026

Fundamentals Snapshot

Annual Revenue
$5M
Last Q Revenue
$1M
P/E Ratio
-0.4
P/S Ratio
0.0x
EPS (TTM)
$-0.94
Dividend Yield
0.00%
Dilution (1yr)
−36.5%

Why Investors Own ALPS

  • ✓High-growth profile — revenue up -7.4% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 26% gross margin and 13% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ALPS logo

ALPS GROUP INC

ALPS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$5M▲ +0.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
8.8%▼ −72.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$3M▼ −0.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$3M▲ +0.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
3.5M▼ −36.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$48K▲ +$6M YoY
StockOtter · stockotter.space

About ALPS GROUP INC

Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
44/100

Analyst Price Target

ⓘ
Average Target
$0.47
▲ +17.9% Upside
High Target$0.53
Low Target$0.44
Based on 28 analysts

Latest News & Updates

🚀
Barron’s·2h ago

ALPS GROUP INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Barron’s·5h ago

Analysts lift ALPS price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Reuters·1d ago

ALPS GROUP INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.